Project Grant AID442F1400001

This Cooperative Agreement award, valued at $400,000.00, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program. The purpose of this award is to support a local organization, the University of Sciences, Techniques and Technologies of Bamako (USTTB) in Mali, to conduct entomological surveillance, insecticide-treated bed net durability monitoring, and routine monitoring of antimalarial drug...

Federal Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Minnesota a $5.07 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, for preclinical development of MMV609, a second-generation ATP4 inhibitor (ATP4i), for malaria treatment. The three-year award, with a completion date of July 31, 2028, supports hypothesis-driven biomedical research aimed at advancing innovative medical solutions...

Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Children's Hospital of Philadelphia (CHOP) a Project Grant of $187,056 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 7, 2025, with a completion date of June 30, 2030. This research project investigates erythrocyte glycolysis as a novel antimalarial strategy to address the urgent global health threat posed by artemisinin-resistant Plasmodium...

This Cooperative Agreement award of $638,820 from the Defense Health Agency supports an mRNA multivalent approach to develop an innovative malaria vaccine. The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to broaden the immune targets against malaria infection by including both pre-erythrocytic-stage antigens and mosquito saliva antigens. The Geneva Foundation, a non-profit research organization, will conduct this research over a 3-year period...

Federal Project Grant Award Summary The Defense Health Agency awarded a $104,069 project grant to University of California, Davis on December 1, 2025, for research and development efforts focused on optimizing a prototype trap for chigger mite surveillance and control. The award, which extends through November 30, 2028, supports research conducted under the Pest Management and Vector Control Research program (CFDA 12.355). This program funds initiatives designed to protect deployed military...

This Cooperative Agreement award of $105,000.00 from the U.S. Department of State's Bureau of African Affairs, under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029), supports Chreso Ministries in Zambia to implement a community-led monitoring project to improve the quality of HIV care. The project involves training community members to collect client feedback and identify gaps in HIV services, with the goal of enhancing the overall quality of HIV care in...

Federal Project Grant Award Summary The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. received a $2.23 million project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, for a three-year performance period concluding August 14, 2028. This award supports research on cryopreservation of human erythrocytes as a strategy to mitigate donor variability and oscillations in mosquito infectivity...

Federal Grant Award Summary The University of South Florida received a $412,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 3, 2025 through June 30, 2027. The award supports research focused on evaluating immunodominant fragments of Plasmodium falciparum Glutamic Acid Rich Protein (PfGARP) for malaria vaccine development. The project builds on prior laboratory...

The Defense Health Agency awarded a $20,465,519.56 Project Grant under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) to Jhpiego Corporation on January 14, 2021 with a completion date of January 13, 2025. The grant will fund efforts to support sustainable HIV epidemic control in Zambia as outlined in the grantee's proposal through the DHAPP-ZDF Partnership. Circle of Hope was awarded four sub-awards totaling $XXX to advise on improving customer care approaches across HIV...

The Defense Health Agency awarded Jhpiego Corporation $933,052 under a Cooperative Agreement from October 1, 2021 to September 30, 2023 to support the Department of Defense HIV/AIDS Prevention Program. As part of this award, Jhpiego will provide reproductive, maternal, newborn, child, and adolescent health services, family health and nutrition activities, voluntary medical male circumcision and pre-exposure prophylaxis services, and health system performance improvement efforts to the Botswana...